Tyrosine Kinase Inhibition to Treat Myeloid Hypereosinophilic Syndrome
Clinical trial NCT00044304 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT00044304
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2002-09-26
- Primary completion
- 2023-11-16
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.